| Literature DB >> 19672143 |
Eleanor A Blakely1, Polly Y Chang.
Abstract
Charged particles have moved from the physics laboratory to the clinic because of their advantageous dose profile and biologic effects. This brief review will summarize the basic phenomenological laboratory data that led to the successful clinical use of these modalities in selected tumor sites, and the emerging new genomic and proteomic research that have provided translational evidence for potential molecular mechanisms underlying some impressive clinical results.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19672143 DOI: 10.1097/PPO.0b013e3181b666c5
Source DB: PubMed Journal: Cancer J ISSN: 1528-9117 Impact factor: 3.360